MEI Pharma, Inc. (MEIP) -NasdaqCM
ayer
1.75$ +0.01 (+0.57%)
seguirla estos días... si se entra controlar para salir pronto
Form 8-K for MEI PHARMA, INC.
24-Mar-2015
Other Events, Financial Statements and Exhibits
Item 8.01 Other Events.
On March 23, 2015, MEI Pharma, Inc. issued a press release announcing top-line data from its randomized Phase II clinical study of Pracinostat in front-line myelodysplastic syndrome. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
